Table 5. Comparison of contemporary reports on oncologic results of pN1 prostate cancer.
| Series | Year | Method of operation | pN1 cases, n | Median follow up (months) | LN yield Median (IQR) |
Survival |
|---|---|---|---|---|---|---|
| Spiess et al.[8] | 2007 | RP | 100 | 62 | 11 (3–32) | 5yr BCRFS 50%; 5yr PFS 84%; 10yr PFS 69%; 5yr CSS 94%; 10yr CSS 75% |
| Touijer et al.[9] | 2014 | RP | 369 | 48 | 15 (10–21) | 5yr BCRFS 54%; 10yr BCRFS 35%; 5yr PFS 79%; 10yr PFS 65%; 5yr CSS 94%; 10yr CSS 72% |
| Seiler et al.[10] | 2014 | RP | 88 | 187 | 21 (6–41) | 10yr BCRFS 8%; 10yr PFS 26%; 10yr CSS58% |
| Nini et al.[12] | 2015 | RP | 800 | 76 | 19 (13–26) | 5yr BCRFS 53.7%; 5yr PFS 50.5%; 5yr CSS 58.8% |
| Moschini et al.[13] | 2015 | RP | 1011 | 211 | 13 (9–18) | 15yr BCRFS 34.1%; 15yr PFS 67%; 15yr CSS 20% |
| Current study | 2016 | RP/RARP | 87 | 60 | 21 (16–29) | 5yr BCRFS 19.1%; 5yr PFS 71%; 5yr CSS 89.6% |
BCRFS = Biochemical recurrence rate free survival; PFS = Progression free survival; CSS = Cancer-specific survival; OS = Overall survival; RP = Radical prostatectomy; RARP = Robot-assisted radical prostatectomy.